NCT06894745View on ClinicalTrials.gov

PET [89Zr]DFO-starPEG in Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Solid TumorSolid CarcinomaSoft Tissue Lesion
Interventions
DRUG

89-zr-dfo-star polyethylene glycol (StarPEG)

Given intravenously (IV)

PROCEDURE

Whole Body Positron Emission Tomography (PET)

Imaging procedure

PROCEDURE

Specimen Collection

Urine and blood specimens will be collected for correlative studies

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

ProLynx LLC
All Listed Sponsors
collaborator

ProLynx LLC

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

Robert Flavell, MD, PhD

OTHER

NCT06894745 - PET [89Zr]DFO-starPEG in Solid Tumors | Biotech Hunter | Biotech Hunter